Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial

BackgroundUnderstanding which group of patients with type 2 diabetes will have the most glucose lowering response to certain medications (which target different aspects of glucose metabolism) is the first step in precision medicine.AimsWe hypothesized that people with type 2 diabetes who generally h...

Full description

Bibliographic Details
Main Authors: Rebecca Brandon, Yannan Jiang, Rui Qian Yeu, Ry Tweedie-Cullen, Kate Smallman, Glenn Doherty, Kerry A. Macaskill-Smith, Rebekah J. Doran, Penny Clark, Allan Moffitt, Troy Merry, Norma Nehren, Frances King, Jennie Harré Hindmarsh, Megan Patricia Leask, Tony R. Merriman, Brandon Orr-Walker, Peter R. Shepherd, Ryan Paul, Rinki Murphy
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1091421/full